A New Chapter for Diabetic Kidney Disease

Many clinical outcomes have improved over the past two decades for people living with diabetes.1 However, relatively little progress has been made in the treatment of diabetic kidney disease. Among adults with diabetes in the United States, the prevalence of diabetic kidney disease has remained steady, near 26%,2 and, depending on the data source, rates of end-stage renal disease (ESRD) have either remained stable or decreased only slightly.1 Why has diabetic kidney disease proved so difficult to prevent and treat? In part, the successes of preventing atherosclerotic complications and prolonging life mean that people with diabetes are exposed to longer . . .